Company profile

EchoNous

Cardiology & Cardiovascular Health

Company profile

About EchoNous

EchoNous is a medical technology company pioneering AI-enhanced point-of-care ultrasound (POCUS) solutions. Founded in 2016 in Redmond, Washington, the company's name translates to 'intelligent sound' — combining echo (sound) with nous (intelligence) — reflecting its mission to integrate artificial intelligence with miniaturized ultrasound technology. EchoNous develops the Kosmos platform, which delivers cart-based ultrasound performance in a portable, handheld form factor. The platform features proprietary deep learning algorithms that provide real-time guidance for image acquisition and automated clinical measurements, enabling both novice and expert users to perform high-quality ultrasound examinations at the bedside. Kosmos offers advanced capabilities previously limited to larger systems, including Pulsed Wave (PW) Doppler, Continuous Wave (CW) Doppler, Tissue Doppler Imaging (TDI), and Color Doppler. The AI suite includes automated ejection fraction calculations, FAST exam anatomical labeling, bladder volume measurements, and auto-preset optimization across cardiac, lung, and abdominal applications. The company serves multiple clinical specialties including emergency medicine, critical care, cardiology, anesthesiology, nephrology, vascular access, family medicine, and OB/GYN. EchoNous manufactures its devices in the United States and maintains HIPAA and SOC2 compliance. The platform is compatible with proprietary displays as well as select Apple iOS and Android tablets, offering flexibility for clinical workflows. With a team comprising experts from ultrasound, AI, industrial design, and software engineering, EchoNous aims to make advanced diagnostic ultrasound accessible and actionable at the point of care.

Company description EchoNous official website

Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at EchoNous?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Abdominal imaging
  • Bladder volume assessment
  • Cardiac function assessment
  • Ejection fraction measurement
  • FAST exam (trauma)
  • Lung ultrasound
  • Vascular access guidance

Who it serves

  • Anesthesiology Departments
  • Cardiology Practices
  • Critical Care Units
  • Emergency Departments
  • Health Systems
  • Nephrology Centers
  • Primary Care Clinics

Deployment & integration

Deployment information is currently being developed.

Geographic context

MarketsEMEA · Japan · United States
Company sourceOfficial website

Company milestones

Platform expansion

June 2026: Expanded Kosmos clinical capabilities with Vascular Auto Flow, advanced cardiac tools, and connectivity features. Launched Kosmos Bladder AI for automated bladder volume calculations. Introduced Kosmos EDU educational application for novice users.

Partnerships

Recorded partners

  • 19 Labs
  • Apple (iOS device compatibility)
  • Us2.ai

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

No source-backed Company products are currently listed.

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Diagnostic accuracy equivalent to experienced scanners

AI-assisted novice users achieving expert-level performance in cardiac assessments

Ejection fraction calculations in seconds

Automated real-time cardiac function analysis at bedside

9-minute echocardiogram

Complete cardiac exam performed by minimally trained user with AI guidance

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from EchoNous

Recent articles published on EchoNous's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Cardiology & Cardiovascular Health

Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon